Consumer Health

During the pandemic Sri Lanka received international support to purchase the necessary medication to help them fight COVID-19. However, due to the current economic crisis the Government of Sri Lanka has had to impose import restrictions due to…

Despite higher standards of living in North Macedonia, economic challenges resulting in low disposable incomes remain, with the situation further exacerbated by the ongoing war in Ukraine. This has led to double-digit inflation, which is increasing…

During the review period, many consumers have been facing financial difficulties as the cost of living in South Africa has been increasing on a monthly basis. For many consumers, their health is an afterthought with most instead prioritising…

The consumer health industry in New Zealand continued to witness robust growth in current value terms in 2023. The year marked a return to a semblance of normality in the country, following the reopening of borders and the lifting of COVID-19…

Despite persistent inflationary pressures in the country and wages that have not yet caught up with market conditions, consumer health recorded growth in 2023. Growth was supported by solid categories, including cough, cold and allergy (hay fever)…

In 2023, increased socialising and the return to post-pandemic habits support the growth of several OTC categories. However, high inflation and a fluctuating exchange rate continue to create uncertainty. Inflation in Costa Rica was 8.27% in 2022, the…

The self-medication trend is growing in South Korea, supporting further sales growth for analgesics, and cough, cold and allergy (hay fever) remedies, especially since the prevalence of the “tripledemic” in the country, consisting of COVID-19,…

While 2022 was characterised by high inflation, persisting supply chain constraints, and the ongoing war in Ukraine, which brought price increases and volume declines across much of consumer health, it benefited from waning COVID-19 cases and the…

Positive sales growth was registered across most categories of consumer health in the Philippines in 2023 as the strong focus on health and wellbeing that has spread among the population since the peak of the COVID-19 pandemic continued to spur…

Consumer health is set to maintain solid current value growth in 2023, with increases across most categories. Analgesics, and cough, cold and allergy (hey fever) remedies are expected to remain the largest OTC categories. Due to their maturity and…

Sales growth of consumer health in El Salvador in 2023 varied across categories. While OTC performed well, growing at above inflation, preventive health categories such as vitamins, dietary supplements and weight management recorded significant…

The Coronavirus (COVID-19) pandemic had a major impact on almost every category within consumer health in the Netherlands. While the COVID-19 situation eased by 2022, 2023 is the first full year after the pandemic in which players, retailers and…

In 2022, consumer health in the Czech Republic was challenged by medicine shortages, which, to some degree, continued in Q1 2023. The lack of some medicines in the Czech Republic and throughout Europe was caused by the disruption of global supply…

Consumer health continues to experience high retail current value growth in 2023, albeit at a slower rate than 2022. Higher costs of materials, ingredients and services are naturally leading to strong price increases in 2023, thereby driving up value…

In 2023, consumer health is no longer influenced by the COVID-19 pandemic, as everyday life has normalized in Bosnia and Herzegovina. Some categories, such as cough, cold allergy (hay fever) remedies, which were negatively impacted during the…

2023 is set to be a strong year for consumer health in the United Arab Emirates. Many categories are expected to see robust current value growth, underpinned by an increase in online distribution channels, as well as an increasingly savvy,…

Kenvue Inc retained its ranking as the second largest company within the consumer health industry after a successful demerger from Johnson & Johnson Inc in May 2023, supported by global power brands like Tylenol, Zyrtec, Imodium and Band-Aid. North…

Emerging from the pandemic, Latin America moved into a period of high inflation, with both factors hitting consumer health sales in 2022. The large Brazilian market was facing new health challenges in the form of arboviruses, especially dengue, in…

After seeing a weakening in its growth rate in 2020, when the pandemic first hit the region, consumer health in Asia Pacific has since been recording strong growth. Further sales increases are expected over the forecast period, driven by factors such…

While coughs, colds and the flu were less prevalent during the home seclusion of 2020, negatively impacting sales of cough and cold remedies in this year, they returned in full in the 2022/2023 winter season, with society fully reopened, boosting…